Showing results (111-120 of 2,254) with videos related to
Sort By:
Pageof 226
Circulation Research|May 15, 2007
Clinical aspects of platelet inhibitors and thrombus formationTelly A Meadows, Deepak L BhattAmerican Heart Journal|August 17, 2004
Clopidogrel added to aspirin versus aspirin alone in secondary prevention and high-risk primary prevention: rationale and design of the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trialDeepak L Bhatt, Eric J Topol, American Heart Journal|April 8, 2003
The Clopidogrel in Unstable Angina to Prevent Recurrent Events (CURE) study: to what extent should the results be generalizable?Gregory P Gerschutz, Deepak L Bhatt, CMAJ Open|June 1, 2019
Trends in elective and ruptured abdominal aortic aneurysm repair by practice setting in Ontario, Canada, from 2003 to 2016: a population-based time-series analysisKonrad Salata, Mohamad A Hussain, Charles de Mestral, et al.Journal of the American Heart Association|October 30, 2018
Statins Reduce Abdominal Aortic Aneurysm Growth, Rupture, and Perioperative Mortality: A Systematic Review and Meta-AnalysisKonrad Salata, Muzammil Syed, Mohamad A Hussain, et al.Clinical Science (London, England : 1979)|April 1, 2005
C-reactive protein and statins: IL-8 as a molecular link?Paul E Szmitko, Subodh VermaJournal of the Cardiometabolic Syndrome|August 7, 2007
C-reactive protein and the metabolic syndrome: useful addition to the cardiovascular risk profile?Paul E Szmitko, Subodh VermaCell Metabolism|August 11, 2016
Empagliflozin's Fuel Hypothesis: Not so SoonGary D Lopaschuk, Subodh VermaThe Canadian Journal of Cardiology|February 25, 2006
The vascular biology of peroxisome proliferator-activated receptors: modulation of atherosclerosisSubodh Verma, Paul E SzmitkoAmerican Journal of Physiology. Heart and Circulatory Physiology|January 18, 2005
Antiatherogenic potential of red wine: clinician updatePaul E Szmitko, Subodh VermaPageof 226